busulfan/ciprofloxacin/melphalan/pentoxifylline/thiotepa

Known as: BU/CPFX/L-PAM/PTX/TSPA 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-2018
01219762018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Nanoparticles (NPs) offer new solutions for the diagnosis and treatment of tumors. However, the anti-tumor effect has not been… (More)
Is this relevant?
2018
2018
How to reduce the resistance of certain tumor cells to paclitaxel (PTX) and related taxoid anticancer drugs is a major challenge… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Fibroblast growth factor receptors, overexpressed on the surface of a variety of tumor cells and on tumor neovasculature, are… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Theragnostic multifunctional nanoparticles hold great promise in simultaneous diagnosis of disease, targeted drug delivery with… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
This study evaluates our initial experience using alemtuzumab induction with rapid corticosteroid elimination in kidney (KTX) and… (More)
Is this relevant?
2004
2004
Hypoxia/reoxygenation (H/R)-induced intestinal injury plays a significant role in the development of necrotizing enterocolitis… (More)
Is this relevant?
1976
1976
One of the objectives of this study was to determine whether or not the absence of parathyroid hormone (PTH) modifies… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
  • table 4
Is this relevant?